2 completed, 1 suspended. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Suspended 1 |
Follow Nanoparticles: new trials by email Literature Review of Nanoparticles trials Research Report on Nanoparticles
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization Autologous total tumor mRNA loaded DOTAP liposome vaccine - Melanoma, Soft Tissue Sarcoma | Phase 1 | Suspended | University of Florida | 18 | 2026-03-17 | 2026-09-17 |
| Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma, LS1681 Trial Laboratory Biomarker Analysis, Nab-paclitaxel/Rituximab-coated Nanoparticle AR160, Pharmacological Study - Recurrent Aggressive Non-Hodgkin Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma | Phase 1 | Completed | Mayo Clinic | 9 | 2019-04-25 | 2023-06-15 |
| A Phase I SAD and MAD Clinical Trial of CNM-Au8 in Healthy Male and Female Volunteers CNM-Au8, Placebo - Healthy Volunteers - Male and Female | Phase 1 | Completed | Clene Nanomedicine | 86 | 2015-04-01 | 2019-06-03 |
Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, B-Cell (1) · Melanoma (1) · Sarcoma (1)
Clene Nanomedicine (1) · Mayo Clinic (1) · University of Florida (1)
United States (2) · Netherlands (1)
G.J. Groeneveld, MD, PhD (1) · Leighton Elliott, MD (1) · Thomas M Habermann (1)
P50CA097274 (1)